New study probes muscle wasting in cirrhosis patients

NCT ID NCT03225677

Recruiting now Knowledge-focused Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to measure how fast muscles build and break down protein in people with cirrhosis (scarring of the liver). Researchers will use special tracers and a single muscle biopsy to get this information. The goal is to better understand muscle wasting, a common problem in cirrhosis. The study involves 20 participants and is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors understand why muscle wasting occurs in cirrhosis, potentially pointing toward future treatments to prevent it.
What could go wrong: This is a very small, early observational study with only 20 participants. It is not testing a treatment, so it may not lead directly to any new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS

Contacts and locations

Locations

Cleveland Clinic Foundation
RECRUITING

Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.